Home » Topics » Disease categories and therapies » Immune

Immune
RSS

IL-12 offers new approach to BMT in leukemia patients

Jan. 20, 1998

MedImmune and SmithKline Beecham finalize vaccine agreement

Jan. 20, 1998

Cantab and Chemo-Sero to develop chickenpox and shingles vaccines

Jan. 19, 1998

Daclizumab efficacy demonstrated in transplant recipients

Jan. 16, 1998

Novel polyspecific antibody-agent conjugates from Immunomedics

Jan. 16, 1998

Dysentery vaccine technology available for licensing from NIH

Jan. 15, 1998

Vertex describes new IMPDH inhibitors

Jan. 14, 1998

Novel thalidomide prodrugs reported in patent literature

Jan. 12, 1998

ABX-CBL evaluated in phase II GVHD trial

Jan. 7, 1998

New immunosuppressants in the pipeline at Merck & Co.

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...